American Century Companies’s Enzo Biochem, Inc. ENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-47,681
Closed -$389K 1350
2017
Q4
$389K Buy
47,681
+352
+0.7% +$3.36K ﹤0.01% 1208
2017
Q3
$496K Hold
47,329
﹤0.01% 1234
2017
Q2
$523K Buy
+47,329
New +$441K ﹤0.01% 1230

Other funds holding ENZ

American Century Companies's ENZ Position: Q1 2018 in Review

American Century Companies sold out of Enzo Biochem, Inc. (ENZ) in Q1 2018, closing a stake of 47,681 shares — an estimated $389K sold.

American Century Companies first reported a position in ENZ in Q2 2017 and held it in 3 quarters. The position peaked at $523K in Q2 2017. 107 funds tracked by Wall St. Rank hold ENZ as of Q1 2018.

  • American Century Companies reported no remaining Enzo Biochem, Inc. position as of Q1 2018 after selling out during the quarter.
  • American Century Companies sold 47,681 Enzo Biochem, Inc. shares in Q1 2018, an estimated $389K.
  • American Century Companies first reported a position in Enzo Biochem, Inc. in Q2 2017 and held it in 3 quarters.
  • American Century Companies's Enzo Biochem, Inc. position peaked at $523K in Q2 2017.
  • 107 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2018.

Based on American Century Companies's 13F filing for Q1 2018, filed 3 May 2018.